Profile data is unavailable for this security.
About the company
BEIJING TONGRENTANG CO., LTD is a China-based company principally engaged in the production and sales of traditional Chinese patent medicines. The Company’s main products consist of liuwei dihuang series, tongren dahuoluo series, tongren niuhuang qingxin series, angong niuhuang series and donkey-hide gelatin series. The Company distributes its products under the brand of Tongrentang. The Company is also involved in the operation of Tongrentang drug stores. The Company distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)17.96bn
- Net income in CNY1.63bn
- Incorporated1997
- Employees16.78k
- LocationBeijing Tongrentang Co LtdNo. 52 Dongxinglong StreetDongcheng DistrictBEIJING 100062ChinaCHN
- Phone+86 1 067179780
- Fax+86 1 067152230
- Websitehttps://gf.tongrentang.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kangmei Pharmaceutical Co Ltd | 5.21bn | 255.55m | 33.27bn | 4.41k | 129.59 | 4.73 | -- | 6.38 | 0.0185 | 0.0185 | 0.3766 | 0.5079 | 0.3626 | 1.45 | 2.55 | 1,182,457.00 | 1.80 | -17.60 | 2.77 | -32.24 | 20.63 | -72.78 | 4.95 | -101.19 | 0.8398 | -- | 0.0346 | -- | 16.60 | -22.17 | 103.81 | -22.83 | -53.51 | -- |
Humanwell Healthcare Group Co Ltd | 25.56bn | 1.96bn | 38.85bn | 17.68k | 19.64 | 2.17 | -- | 1.52 | 1.21 | 1.21 | 15.87 | 10.95 | 0.6902 | 3.80 | 2.74 | 1,445,825.00 | 7.13 | 6.20 | 13.12 | 12.72 | 45.59 | 42.82 | 10.33 | 9.84 | 1.21 | 12.09 | 0.3171 | 18.87 | 9.79 | 5.65 | -14.07 | -- | 8.25 | -- |
Beijing Tiantan Biological Products Corp | 5.23bn | 1.27bn | 43.56bn | 4.86k | 34.19 | 4.09 | -- | 8.33 | 0.6444 | 0.6444 | 2.65 | 5.38 | 0.3471 | 0.8137 | 198.92 | 1,076,946.00 | 11.47 | 11.71 | 16.75 | 16.50 | 54.23 | 49.39 | 33.05 | 27.71 | 3.31 | -- | 0.0046 | 16.67 | 21.57 | 12.06 | 25.99 | 16.85 | 29.67 | 38.97 |
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 76.39bn | 3.42bn | 44.37bn | 28.05k | 13.74 | 1.30 | -- | 0.5808 | 2.11 | 2.11 | 46.99 | 22.28 | 0.9946 | 6.07 | 4.60 | 2,723,576.00 | 4.71 | 5.90 | 8.93 | 12.40 | 16.55 | 18.70 | 4.74 | 5.56 | 1.15 | -- | 0.317 | 30.02 | 6.68 | 12.32 | 2.25 | 3.34 | 27.75 | 12.05 |
Beijing Tongrentang Co Ltd | 17.96bn | 1.63bn | 56.09bn | 16.78k | 34.45 | 4.32 | -- | 3.12 | 1.19 | 1.19 | 13.09 | 9.46 | 0.5912 | 1.08 | 11.14 | 1,070,467.00 | 7.88 | 8.20 | 15.63 | 16.17 | 44.48 | 46.59 | 13.33 | 13.33 | 1.58 | -- | 0.1765 | 30.93 | 16.19 | 4.68 | 16.92 | 8.03 | -12.01 | 13.97 |
Shanghai Fosun Pharmaceutical (Group) | 41.61bn | 2.11bn | 65.23bn | 40.37k | 34.62 | 1.54 | -- | 1.57 | 0.7883 | 0.7883 | 15.54 | 17.71 | 0.3682 | 2.86 | 5.10 | 1,030,748.00 | 2.44 | 4.31 | 4.18 | 7.01 | 47.10 | 50.71 | 6.63 | 10.65 | 0.7221 | -- | 0.3755 | 31.92 | -5.81 | 10.69 | -36.04 | -2.50 | 10.95 | -3.34 |
Sichuan Biokin Pharmaceutical Co Ltd | 5.85bn | 3.80bn | 80.56bn | 2.09k | 21.20 | 18.99 | -- | 13.78 | 9.48 | 9.48 | 14.58 | 10.58 | 1.40 | 1.81 | 64.16 | 2,802,843.00 | 90.79 | -- | 138.20 | -- | 95.33 | -- | 64.99 | -- | 2.89 | -- | 0.2807 | -- | -20.11 | -- | -176.40 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Beijing Tongrentang Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Zhong Ou Asset Management Co., Ltdas of 30 Sep 2023 | 62.27m | 4.54% |
Perseverance Asset Management LPas of 30 Sep 2023 | 31.50m | 2.30% |
China Universal Asset Management Co., Ltd.as of 30 Sep 2023 | 14.46m | 1.05% |
E Fund Management Co., Ltd.as of 30 Sep 2023 | 10.82m | 0.79% |
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2024 | 9.65m | 0.70% |
Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 7.97m | 0.58% |
GF Fund Management Co., Ltd.as of 30 Jun 2024 | 7.70m | 0.56% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Sep 2023 | 6.00m | 0.44% |
Minsheng Royal Fund Management Co., Ltd.as of 30 Jun 2024 | 4.74m | 0.35% |
Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 4.40m | 0.32% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.